
Losartan Carboxaldehyde
CAS No. 114798-36-6
Losartan Carboxaldehyde( —— )
Catalog No. M21093 CAS No. 114798-36-6
Losartan Carboxaldehyde is an endothelial cyclooxygenase (COX)-2 inhibitor.
Purity : >98% (HPLC)






Size | Price / USD | Stock | Quantity |
5MG | 110 | Get Quote |
![]() ![]() |
10MG | 177 | Get Quote |
![]() ![]() |
25MG | 385 | Get Quote |
![]() ![]() |
50MG | 575 | Get Quote |
![]() ![]() |
100MG | 801 | Get Quote |
![]() ![]() |
200MG | Get Quote | Get Quote |
![]() ![]() |
500MG | Get Quote | Get Quote |
![]() ![]() |
1G | Get Quote | Get Quote |
![]() ![]() |
Biological Information
-
Product NameLosartan Carboxaldehyde
-
NoteResearch use only, not for human use.
-
Brief DescriptionLosartan Carboxaldehyde is an endothelial cyclooxygenase (COX)-2 inhibitor.
-
DescriptionLosartan Carboxaldehyde is an endothelial cyclooxygenase (COX)-2 inhibitor.
-
In Vitro——
-
In Vivo——
-
Synonyms——
-
PathwayChromatin/Epigenetic
-
TargetCOX
-
RecptorCOX-2
-
Research Area——
-
Indication——
Chemical Information
-
CAS Number114798-36-6
-
Formula Weight420.8
-
Molecular FormulaC22H21ClN6O
-
Purity>98% (HPLC)
-
SolubilityIn Vitro:?DMSO : 125 mg/mL (296.99 mM)
-
SMILESCCCCc1nc(Cl)c(C=O)n1Cc1ccc(-c2ccccc2-c2nn[nH]n2)cc1
-
Chemical Name——
Shipping & Storage Information
-
Storage(-20℃)
-
ShippingWith Ice Pack
-
Stability≥ 2 years
Reference



-
Lornoxicam
Lornoxicam (chlortenoxicam) is a new nonsteroidal anti-inflammatory drug (NSAID) of the oxicam class with analgesic, anti-inflammatory and antipyretic properties.
-
Indobufen
Indobufen is an inhibitor of platelet aggregation and is a reversible platelet cyclooxygenase (Cox) activity inhibitor. Indobufen suppresses thromboxane A2 (TxA2) synthesis. Indobufen down-regulates tissue factor (TF) in monocytes.
-
Etoricoxib
Etoricoxib(MK-0663) selectively inhibited COX-2 in human whole blood assays in vitro, with an IC50 value of 1.1 ± 0.1 μM for COX-2 (LPS-induced prostaglandin E2 synthesis), compared with an IC50 value of 116 ± 8 μM for COX-1 (serum thromboxane B2 generation after clotting of the blood).